-
Product Insights
NewGerm Cell Tumors – Drugs In Development, 2024
Empower your strategies with our Germ Cell Tumors – Drugs In Development, 2024 report and make more profitable business decisions. Germ cell tumors (GCTs), originating from primordial germ cells, exhibit diverse neoplasms primarily in gonads but also in the anterior mediastinum, pineal gland, and brain. Clinical classification distinguishes seminomas and non-seminomas, each with distinct prognoses. Seminomas typically show favorable outcomes, while non-seminomatous tumors may present with metastasis, including mixed germ cell components. Diagnosing germinoma involves imaging, serum/cerebrospinal fluid oncoprotein measurements, and...
-
Product Insights
NewNongerminomatous (Nonseminomatous) Germ Cell Tumors – Drugs In Development, 2024
Empower your strategies with our Nongerminomatous (Nonseminomatous) Germ Cell Tumors – Drugs In Development, 2024 report and make more profitable business decisions. The most common type of testis cancer is a germ cell tumor (GCT). There are two main types of GCT, seminoma and nonseminomatous germ cell tumor (NSGCT). Both seminoma and NSGCT occur at about the same rate, and men can have seminoma, NSGCTs, or a combination of both. There are four main types of NSGCT that can appear alone,...
-
Product Insights
NewNodal Marginal Zone B-Cell Lymphoma – Drugs In Development, 2024
Empower your strategies with our Nodal Marginal Zone B-Cell Lymphoma – Drugs In Development, 2024 report and make more profitable business decisions. Nodal marginal zone B-cell lymphoma (NMZL) is a rare type of non-Hodgkin lymphoma that affects the lymph nodes. It is a slow-growing cancer that can sometimes become aggressive. NMZL is more common in older adults, but it can occur in younger people as well. The exact cause of NMZL is unknown, but some genetic factors may be involved. NMZL...
-
Product Insights
NewSplenic Marginal Zone B-Cell Lymphoma – Drugs In Development, 2024
Empower your strategies with our Splenic Marginal Zone B-Cell Lymphoma – Drugs In Development, 2024 report and make more profitable business decisions. Splenic marginal zone lymphoma (SMZL) is a rare type of B-cell lymphoma that affects the spleen, bone marrow, and sometimes the blood. It is a low-grade neoplasm that originates from the germinal centers of the splenic white pulp. The neoplastic cells are small lymphocytes and larger transformed lymphoblasts that invade the mantle and marginal zones of the spleen and...
-
Product Insights
NewHypopharyngeal Cancer – Drugs In Development, 2024
Empower your strategies with our Hypopharyngeal Cancer – Drugs In Development, 2024 report and make more profitable business decisions. Hypopharyngeal cancer is a term used for tumors of a subsite of the upper aerodigestive tract, and like most other subsite designations, the distinction is anatomic rather than pathophysiologic within the group of head and neck malignancies. The hypopharynx is the region between the oropharynx above (at the level of the hyoid bone) and the esophageal inlet below (at the lower end...
-
Product Insights
NewBurkitt Lymphoma – Drugs In Development, 2024
Empower your strategies with our Burkitt Lymphoma – Drugs In Development, 2024 report and make more profitable business decisions. Burkitt lymphoma is an aggressive and fast-growing type of non-Hodgkin lymphoma (NHL) that primarily affects B cells, a type of white blood cell involved in the immune system. It is named after Denis Burkitt, a surgeon who described the disease in African children in the 1950s. There are three main types of Burkitt lymphoma. Endemic Burkitt lymphoma is most commonly found in...
-
Product Insights
NewLaryngeal Cancer – Drugs In Development, 2024
Empower your strategies with our Laryngeal Cancer – Drugs In Development, 2024 report and make more profitable business decisions. Laryngeal cancer is a disease in which malignant (cancer) cells form in the tissues of the larynx. Most laryngeal cancers form in squamous cells, the thin, flat cells lining the inside of the larynx. Symptoms include persistent hoarseness, difficulty swallowing, sore throat, or a lump in the neck. Treatment involves a combination of surgery, radiation therapy, and chemotherapy. Early detection is crucial...
-
Product Insights
NewExtranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associated Lymphoid Tissue or MALT-Lymphoma) – Drugs In Development, 2024
Empower your strategies with our Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associated Lymphoid Tissue or MALT-Lymphoma) – Drugs In Development, 2024 report and make more profitable business decisions. Extranodal marginal zone B-cell lymphoma (EMZL), also known as mucosa-associated lymphoid tissue (MALT) lymphoma, is a rare type of non-Hodgkin lymphoma that originates in the marginal zone B cells outside of the lymph nodes. It often develops in various extranodal sites of the body, particularly mucosal tissues such as the stomach, salivary glands, lungs,...
-
Product Insights
NewOropharyngeal Cancer – Drugs In Development, 2024
Empower your strategies with our Oropharyngeal Cancer – Drugs In Development, 2024 report and make more profitable business decisions. Oropharyngeal cancer is a disease in which malignant cells form in the tissue of oropharynx. The oropharynx is the middle part of the throat and includes the base of the tongue, the tonsils, the soft palate, and the walls of the pharynx. Oropharyngeal cancers can be divided into two types: HPV-positive, which are related to human papillomavirus infection; and HPV-negative cancers, which...
-
Product Insights
NewSquamous Non-Small Cell Lung Cancer – Drugs In Development, 2024
Empower your strategies with our Squamous Non-Small Cell Lung Cancer – Drugs In Development, 2024 report and make more profitable business decisions. Squamous cell carcinoma is a subtype of non-small cell lung cancer (NSCLC) originating in the squamous cells lining the airways. It constitutes about 25-30% of all lung cancers. Linked to smoking, symptoms include persistent cough, chest pain, and breathing difficulties. Diagnosis involves imaging, biopsy, and staging to determine the cancer's extent. Treatment options depend on the stage but may...